There has been recent change in the nomenclature of nonalcoholic fatty liver disease (NAFLD) to Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD). Significant advances have also happened in the field of noninvasive testing (NITs) and therapy of MASLD in the last couple of years.
-
Your Cart $353.00
-
×
EXTRAPULMONARY TUBERCULOSIS In stock
2 × $20.00 -
×
COVID-19 Comprehensive Review In stock
1 × $25.00 -
×
CARDIOLOGY Update 2021 In stock
1 × $130.00 -
×
Viral Infection in Pregnancy In stock
1 × $25.00 -
×
Tropical Rheumatology In stock
1 × $20.00 -
×
Emerging and Re-emerging INFECTIOUS DISEASES In stock
1 × $23.00 -
×
Cardiology Update 2019 (Official Publication of CSI) In stock
1 × $90.00
Subtotal: $353.00
-
×
-
8
-
×
EXTRAPULMONARY TUBERCULOSIS
In stock
2 × $20.00 -
×
COVID-19 Comprehensive Review
In stock
1 × $25.00 -
×
CARDIOLOGY Update 2021
In stock
1 × $130.00 -
×
Viral Infection in Pregnancy
In stock
1 × $25.00 -
×
Tropical Rheumatology
In stock
1 × $20.00 -
×
Emerging and Re-emerging INFECTIOUS DISEASES
In stock
1 × $23.00 -
×
Cardiology Update 2019 (Official Publication of CSI)
In stock
1 × $90.00
Subtotal: $353.00
-
×
Related products
